A

Allegheny Health Network | Allegheny Endocrinology Associates

Research site
(Unclaimed)
Location
420 East North Avenue, Suite 205, Pittsburgh, Pennsylvania, United States of America
Site insights

Top conditions

Acromegaly (7 trials)

Gastroparesis (4 trials)

Cardiovascular Diseases (2 trials)

Pituitary ACTH Hypersecretion (2 trials)

ACTH-Secreting Pituitary Adenoma (2 trials)

Top treatments

Octreotide
Relamorelin
Bococizumab
Pasireotide
Paltusotine
LY3437943
Somatostatin
SOM230

Parent organization

This site is a part of Allegheny Health Network

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

1 of 18
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

The purpose of this trial is to assess the long-term safety and efficacy of CAM2029 in patients with acromegaly. Patients will be administered CAM202...

Active, not recruiting
Acromegaly
Drug: CAM2029 (octreotide subcutaneous depot)

Trial sponsors

Allergan logo

Allergan (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems